Answers are grounded in this paper and cite their sources.
Synergistic activation of innate immunity and adaptive immunity provides a promising way to improve cancer immunotherapy, but achieving their precise and co-activation remains a major challenge. Here, we constructed a copper-doped manganese vacancy (V Mn )-engineered Prussian blue derivative (CuV Mn -PBA) as a dual functional pyroptosis-cyclic GMP-AMP synthase-stimulator of interferon genes signaling (cGAS-STING) activator for second near-infrared region (NIR-II) photoimmunotherapy. The V Mn induced by acid etching narrowed the bandgap and enhanced NIR-II absorption at 1060 nm, while Cu doping acted as electron-trapping sites to promote electron–hole separation, jointly boosting multienzymatic/photocatalytic activity. Under 1060 nm laser irradiation, this dual modification enabled robust reactive oxygen species (ROS) generation even in hypoxia. Excessive ROS-induced oxidative stress triggered gasdermin E-mediated tumor cell pyroptosis, driving mitochondrial DNA (mtDNA) release into the cytoplasm, which cooperated with dissociated Mn 2+ and pyroptosis-derived inflammatory factors to activate the cGAS-STING pathway. This cascade elevated tumor immunogenicity, promoted dendritic cells (DCs) maturation and cytotoxic T lymphocytes (CTLs) infiltration, and established long-term antitumor immune memory. In combination with αPD-1 checkpoint blockade, CuV Mn -PBA mediated complete primary tumor regression, suppressed distant tumor growth, and abrogated tumor recurrence, offering a promising paradigm for enhanced cancer photoimmunotherapy.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: